Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis

There is accumulating evidence that ALS is a multisystem degenerative disease, raising the question of whether some symptoms are of extrapyramidal origin. The objective was to better characterize the type of stiffness in a series of ALS patients and to study correlations with balance and postural impairment. We studied ALS patients who exhibited stiffness without noticeable motor deficit in the lower limbs. We analyzed the response to manual stretch velocity to differentiate between extrapyramidal (rigidity) or pyramidal (spasticity) stiffness, shortening reaction in the tibialis anterior muscles (abolished in pyramidal diseases and exaggerated in extrapyramidal diseases) and balance and posture impairment (UPDRS and Berg's scale). After a preliminary inter‐rater reliability study, 39 consecutive ALS patients were prospectively recruited. Each patient was randomly assigned to one or other of two investigators who evaluated either stiffness or balance impairment. In the lower limbs, rigidity was observed in at least one muscle in 27/39 patients (69%), and shortening reaction was exaggerated in 20/39 patients (51%). Both were correlated with balance and posture impairment (UPDRS and Berg's scale, P < 0.001). This study suggests that extrapyramidal involvement plays a role in stiffness and balance impairment in a subset of ALS patients. © 2009 Movement Disorder Society

[1]  N. Quinn,et al.  Primary lateral sclerosis mimicking atypical parkinsonism , 2007, Movement disorders : official journal of the Movement Disorder Society.

[2]  S. Tsuji,et al.  A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis. , 2006, Archives of neurology.

[3]  W. Rymer,et al.  The role of shortening reaction in mediating rigidity in Parkinson’s disease , 2004, Experimental Brain Research.

[4]  P N Leigh,et al.  Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. , 2000, Brain : a journal of neurology.

[5]  W. Oyen,et al.  Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration , 2000, Journal of the Neurological Sciences.

[6]  J. Cedarbaum,et al.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.

[7]  M. Swash,et al.  Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion , 1999, Journal of neurology, neurosurgery, and psychiatry.

[8]  M. Horstink,et al.  Decreased striatal dopamine-receptor binding in sporadic ALS: Glutamate hyperactivity? , 1999, Neurology.

[9]  G. Borasio,et al.  Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography , 1998, Journal of neurology, neurosurgery, and psychiatry.

[10]  L S Illis,et al.  Neurotrauma , 1998, Spinal Cord.

[11]  J. Lowe,et al.  Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. , 1998, Neuropathology and applied neurobiology.

[12]  S. Tsuji,et al.  Neuropathology of sporadic amyotrophic lateral sclerosis of long duration , 1997, Journal of the Neurological Sciences.

[13]  V. Dhawan,et al.  Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations , 1996, Neurology.

[14]  R. Ruff,et al.  Principles of Neurology, 5th Ed. , 1995, Neurology.

[15]  S. Wood-Dauphinée,et al.  The Balance Scale: reliability assessment with elderly residents and patients with an acute stroke. , 1995, Scandinavian journal of rehabilitation medicine.

[16]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[17]  B. Snow,et al.  Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning , 1993, The Lancet.

[18]  M. Oda,et al.  Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis , 1993, Neuropathology and applied neurobiology.

[19]  P. Blumbergs,et al.  Substantia nigra degeneration in motor neurone disease: a quantitative study. , 1992, Australian and New Zealand journal of medicine.

[20]  E. Borrelli,et al.  Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum. , 1992, Brain research. Molecular brain research.

[21]  Richard W. Bohannon,et al.  Interrater reliability of a modified Ashworth scale of muscle spasticity. , 1987, Physical therapy.

[22]  R. Angel Shortening reaction in normal and parkinsonian subjects , 1982, Neurology.

[23]  W. Grove Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[24]  F. Norris,et al.  Trial of baclofen in amyotrophic lateral sclerosis. , 1979, Archives of neurology.

[25]  R. Angel,et al.  Unloading and shortening reactions in Parkinson's disease. , 1978, Journal of neurology, neurosurgery, and psychiatry.

[26]  P. Rondot,et al.  Muscle reaction to passive shortening in normal man. , 1978, Electroencephalography and clinical neurophysiology.

[27]  A. Faurbye,et al.  DEPOSITS IN THE LENS AND CORNEA OF THE EYE DURING LONG‐TERM CHLORPROMAZINE MEDICATION , 1976, Acta psychiatrica Scandinavica.

[28]  W. Conover Statistical Methods for Rates and Proportions , 1974 .

[29]  P. Castaigne,et al.  [Neuropathological study of 61 cases of amyotrophic lateral sclerosis. Nosological discussion]. , 1972, Revue neurologique.

[30]  J. Scherrer,et al.  [Reflex contraction induced by passive shortening of the muscle in athetosis and position dystonias]. , 1966, Revue neurologique.

[31]  C. Westphal Unterschenkelphänomen und Nervendehnung , 1877, Archiv für Psychiatrie und Nervenkrankheiten.

[32]  Y. Tsutsumi,et al.  Sporadic amyotrophic lateral sclerosis with extensive neurological involvement , 2004, Acta Neuropathologica.

[33]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[34]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[35]  C. Broberg,et al.  Measurement of torque during passive and active ankle movements in patients with muscle hypertonia. A methodological study. , 1983, Scandinavian journal of rehabilitation medicine. Supplement.

[36]  D. Burke,et al.  The response to muscle stretch and shortening in Parkinsonian rigidity. , 1972, Brain : a journal of neurology.